Search
Claudia Satizabal, PhD, Department of Population Health Sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Claudia Satizabal, PhD, Department of Population Health Sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
UT Health San Antonio awarded $12.6 million grant for cancer research, understanding drug resistance
Content by Claire Kowalick The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a collaborative $12.6 million program project grant from the National Cancer Institute to define the functions and regulation of BRCA1, BRCA2 and related tumor suppressor genes and find new ways to combat cancer. The $12.6 million grant […]
Claudia Satizabal, PhD, Department of Population Health Sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Claudia Satizabal, PhD, Department of Population Health Sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Dear Faculty, Staff and Students, In our last update, we introduced the process to unify UTSA and UT Health San Antonio into one world class university. In that message, we also announced the launch of an integration website to serve as a resource for updates, timelines, progress and more. Today, we’re writing to share the […]
The School of Dentistry was mentioned in this article. Read More
Employee BOGO offer; student and resident free ticket offer To celebrate the exciting integration with The University of Texas at San Antonio (UTSA), UT Health San Antonio employees can buy one ticket and get one free to cheer on the UTSA Roadrunners as they take on the Florida Atlantic Owls at their Homecoming/Family Weekend game at the […]
UT Health San Antonio was mentioned in this opinion article. Read More
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected to […]